ÂÜÀòÂÒÂ×

Karni Schlessinger serves as the VP and Head of Global Regulatory Affairs for Oncology at Boehringer Ingelheim since August 2018, following roles as Executive Director and Director in the same field. Prior experience includes nearly nine years at Merck, where Karni held several positions, notably as Director of Regulatory Affairs for Oncology/Immunology, focusing on products like Keytruda. Academic credentials include a Ph.D. in Basic Biomedical Studies from New York Medicine Jobs and a B.Sc. in Biology from The Hebrew University of Jerusalem. Research experience encompasses a postdoctoral fellowship at the University College London and a Sr. Research Biologist role at Memorial Sloan Kettering Cancer Center, alongside earlier positions as a research assistant. Karni possesses expertise in global regulatory affairs, oncology, immunology, and preclinical research.